Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?

The aim of review. To estimate possible interrelation between bacterial overgrowth syndromes in the small intestine (BOS) and irritable bowel syndrome (IBS).Key points. BOS and IBS are extremely common syndromes, that contributes to their casual coexistence within same patient from epidemiological p...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yu. A. Kucheryavy, S. V. Cheryomushkin, Ye. A. Mayevskaya, Ye. A. Sutugina
Format:	Article
Language:	Russian
Published:	Gastro LLC 2014-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	bacterial overgrowth syndrome in the small intestine irritable bowel syndrome treatment diosmectite
Online Access:	https://www.gastro-j.ru/jour/article/view/1097
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease
by: K. V. Ivashkin, et al.
Published: (2021-04-01)

Bacterial overgrowth syndrome
by: Yu. A. Kucheryavy, et al.
Published: (2010-11-01)

Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Irritable Bowel Syndrome who Have Suffered COVID-19
by: A. V. Nalyotov, et al.
Published: (2022-09-01)

Comparative efficacy of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> composition and prucalopride in treatment of constipation variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-07-01)

Comparative assessment of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> and <i>Saccharomyces boulardii</i> efficacy at diarrheal variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-05-01)

Small Bowel Bacterial Overgrowth Syndrome in Patients with Bronchial Asthma
by: N. D. Potskhverashvili, et al.
Published: (2018-09-01)

The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2012-09-01)

Treatment of irritable bowel syndrome: the past, present and future
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

What Do Gases in the Large Intestine Have to Do with Health?
by: Klaudia Pawełek, et al.
Published: (2025-02-01)

Prevalence, Diagnostics and Treatment of Small Intestinal Bacterial Overgrowth in the Clinical Practice in Southern Federal District of the Russian Federation
by: N. V. Korochanskaya, et al.
Published: (2025-02-01)

Gastroesophageal reflux disease and the functional diseases of gastro-intestinal tract: are there any interrelations?
by: A. A. Sheptulin, et al.
Published: (2010-08-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Practical Recommendation of the Scientific Сommunity for Human Microbiome Research (CHMR) and the Russian Gastroenterological Association (RGA) on Small Intestinal Bacterial Overgrowth in Adults
by: V. T. Ivashkin, et al.
Published: (2022-09-01)

Pathogenic role of intestinal microflora changes in patients with irritable bowel syndrome and treatment options
by: Ye. A. Poluektova, et al.
Published: (2014-09-01)

Small Intestinal Bacterial Overgrowth in Various Specialties of Medical Practice (Literature Review and Expert Council Resolution)
by: V. T. Ivashkin, et al.
Published: (2024-05-01)

Pathogenetic Substantiation of the Therapeutic Impact on Microbiota in Irritable Bowel Syndrome
by: Yu. O. Shulpekova, et al.
Published: (2019-09-01)

Modern concept of bacterial complications at liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2010-12-01)

Irritable bowel syndrome: pathophysiological and clinical issues
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis
by: Ye. A. Poluektova, et al.
Published: (2013-03-01)

Small Intestinal Bacterial Overgrowth Syndrome as a Risk Factor for Ventricular Tachycardia in Chronic Heart Failure with Left Ventricular Systolic Dysfunction
by: M. V. Fadeeva, et al.
Published: (2019-06-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia
by: V. T. Ivashkin, et al.
Published: (2022-01-01)

Use of Bismuth in Irritable Bowel Syndrome
by: T. A. Ilchishina
Published: (2021-10-01)

Issues of diagnostics and treatment of abdominal pain at irritable bowel syndrome at outpatient stage of the healthcare
by: Yu. A. Kucheryavy, et al.
Published: (2015-12-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

Discussion of the problem of functional constipation and irritable bowel syndrome in the reports of the International Congress on Neurogastroenterology and Motility (Bologna, 2012)
by: A. A. Sheptulin, et al.
Published: (2013-03-01)

Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers
by: Yu. O. Shulpekova
Published: (2011-02-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

Combined alverine citrate and simeticonein preparation in the treatment of irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2012-07-01)

COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01)

Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease?
by: A. A. Sheptulin, et al.
Published: (2019-12-01)

Role of nutritional factors at the irritable bowel syndrome
by: Yu. O. Shulpekova, et al.
Published: (2015-10-01)

Role of emotional disorders, personality features and disorders of intraceptive sensation in development of somatic symptoms at irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2013-12-01)

Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
by: O. V. Krapivnaya
Published: (2014-07-01)

Irritable Bowel Syndrome Onset after New Coronavirus Infection COVID-19
by: I. Yu. Feklina, et al.
Published: (2022-03-01)

Effect of combined therapy by pinaverium bromide and itopride hydrochloride on clinical semiology and quality of life of patients with combination of constipation variant of irritable bowel syndrome and functional dyspepsia
by: O. V. Krapivnaya, et al.
Published: (2015-05-01)

Irritable Bowel Syndrome: What Are the Reasons for Dissatisfaction with the Treatment of Patients and Doctors? (Based on the Experience of Medical Institutions of the Northwestern Federal District of Russia)
by: A. Yu. Baranovsky, et al.
Published: (2024-01-01)

Management of a Female Patient with Irritable Bowel Syndrome and Somatoform Disorder
by: E. A. Trush, et al.
Published: (2023-02-01)

Esophageal lesions at irritable bowel syndrome
by: M. G. Mnatsakanyan, et al.
Published: (2015-10-01)